Alexander Kaganowicz Net Worth

The estimated Net Worth of Alexander Kaganowicz is at least $483 Thousand dollars as of 14 June 2024. Alexander Kaganowicz owns over 2,000 units of Research Frontiers stock worth over $326,548 and over the last 11 years he sold REFR stock worth over $0. In addition, he makes $156,760 as Independent Director at Research Frontiers.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Alexander Kaganowicz REFR stock SEC Form 4 insiders trading

Alexander has made over 26 trades of the Research Frontiers stock since 2013, according to the Form 4 filled with the SEC. Most recently he bought 2,000 units of REFR stock worth $3,880 on 14 June 2024.

The largest trade he's ever made was buying 10,000 units of Research Frontiers stock on 25 June 2018 worth over $7,900. On average, Alexander trades about 1,872 units every 102 days since 2013. As of 14 June 2024 he still owns at least 164,923 units of Research Frontiers stock.

You can see the complete history of Alexander Kaganowicz stock trades at the bottom of the page.

Alexander Kaganowicz biography

Dr. Alexander Kaganowicz serves as Independent Director of the Company. He has been a shareholder of Research Frontiers since 1998 and has been a director of the Company since June 2013. Dr. Kaganowicz is the Chairman of the Company’s Nominating and Corporate Governance Committee and is a member of the Audit and Compensation and Stock Option Committees. In addition to being a shareholder, Dr. Kaganowicz has been involved in the performance and market testing of SPD products, including several demonstration installations of SPD SmartGlass in his home and work locations. For the past 30 years Dr. Kaganowicz has been the proprietor of a successful automotive services business in Freeport, NY. He holds a Doctorate in Chemistry from the University of Rome, has served as Adjunct Associate Professor at the New York Institute of Technology, and has worked as a clinical chemist with titles of Director of the Chemistry Department and Manager of the Pathology Department at the Booth Memorial Medical Center in Queens, NY (from 1974 to 1989). In addition, he owned and operated several successful medical supply companies in New York and Pennsylvania from 1989 to 2005. Dr. Kaganowicz research experience has resulted in several publications and textbook contributions.

What is the salary of Alexander Kaganowicz?

As the Independent Director of Research Frontiers, the total compensation of Alexander Kaganowicz at Research Frontiers is $156,760. There are 3 executives at Research Frontiers getting paid more, with Joseph Harary having the highest compensation of $804,605.

How old is Alexander Kaganowicz?

Alexander Kaganowicz is 73, he's been the Independent Director of Research Frontiers since 2013. There are no older and 7 younger executives at Research Frontiers.

What's Alexander Kaganowicz's mailing address?

Alexander's mailing address filed with the SEC is 240 CROSSWAYS PARK DRIVE, , WOODBURY,, NY, 11797.

Insiders trading at Research Frontiers

Over the last 21 years, insiders at Research Frontiers have traded over $4,323,250 worth of Research Frontiers stock and bought 1,885,771 units worth $7,004,119 . The most active insiders traders include Kevindouglas Family Trustja..., Kevin Douglas, and Victor F Keen. On average, Research Frontiers executives and independent directors trade stock every 42 days with the average trade being worth of $32,062. The most recent stock trade was executed by Alexander Kaganowicz on 14 June 2024, trading 2,000 units of REFR stock currently worth $3,880.

What does Research Frontiers do?

research frontiers inc., the developers and licensors of spd-smartglass™, have built an infrastructure of over 40 licensees worldwide that collectively are capable of serving the growing global demand for smart glass products in automobiles, homes, buildings, aircraft, boats and display applications. in suspended particle devices (spds), a thin film laminate of rod-like nano-scale particles is suspended in a liquid and placed in between two pieces of glass or plastic, or attached to one layer. when no voltage is applied, the suspended particles are randomly organized, thus blocking and absorbing light. when voltage is applied, the suspended particles align and let light pass. varying the voltage of the film varies the orientation of the suspended particles, thereby regulating the tint of the glazing and the amount of light transmitted. spds can be manually or automatically "tuned"​ to precisely control the amount of light, glare and heat passing through, reducing the need for air condi

Complete history of Alexander Kaganowicz stock trades at Research Frontiers

Research Frontiers executives and stock owners

Research Frontiers executives and other stock owners filed with the SEC include:

• Joseph Harary,
  President, Chief Executive Officer, General Counsel, Corporate Secretary, Director
• Joseph M. Harary,
  CEO, Pres, Gen. Counsel, Corp. Sec. & Director
• Seth Van Voorhees,
  Chief Financial Officer, Vice President - Business Development
• Alexander Kaganowicz,
  Independent Director
• Darryl Daigle,
  Independent Director
• Michael LaPointe,
  Vice President - Aerospace Products
• Michael R. LaPointe,
  VP of Aerospace Products
• William Settle,
  Director
• Steven Michael Slovak,
  Vice President-Technology
• Gregory George Grimes,
  Director
• Kevindouglas Family Trustja...,
  
• Kevinjames & Jean Douglas I...,
  
• Robert M Budin,
  Director
• Robert L Saxe,
  Chairman of the Board
• Victor F Keen,
  Director
• Richard James Hermon Taylor,
  Director
• Marion Philip Guthrie,
  Director
• Jack Derby,
  Director
• Albert P Malvino,
  Director
• Kevin Douglas,
  10% owner
• Eyal Peso,
  Director